TOPEKA | Kansas expects to receive nearly $741,000 from a settlement with a drug manufacturer over how it promoted two painkillers.
Kansas had joined 32 other states in investigating Pfizer Inc.
Pfizer faced allegations of promoting the now-discontinued painkiller Bextra for “off-label” uses, or uses it was not approved for. States also questioned whether Pfizer improperly promoted another drug, Celebrex, as safer than some over-the-counter medications.
In agreeing to a $60 million settlement with the states, Pfizer denied its promotional practices violated any laws.
Never miss a local story.
Attorney General Steve Six says Kansas will use its part of the settlement to cover its legal expenses, expand consumer education and finance consumer protection efforts.